Literature DB >> 33947143

Characterization and Safety Profile of Transfer Factors Peptides, a Nutritional Supplement for Immune System Regulation.

Hudson Polonini1, Any Elisa de Souza Schmidt Gonçalves2, Eli Dijkers1, Anderson de Oliveira Ferreira1.   

Abstract

Imuno TF® is a nutritional supplement composed of isolated transfer factors (TF) from porcine spleen. It is composed of a specific mixture of molecules that impact functions of the biological systems and historically is linked to the immune system regulation. In this study, we demonstrate for the first time its proteomic analysis, nutritional composition, and safety profile in terms of mutagenic potential and acute oral dose (LD50). The obtained analysis indicated the product is a complex set of oligo- and polypeptides constituted of 163 different peptides which can potentially act on multiple mechanisms on the immune system pathways. The chemical composition showed low fat and low sugar content, saturated fatty acids-free, and the presence of 10 vitamins and 11 minerals. No mutagenic effect was observed, and the LD50 was 5000 mg kg-1 body weight. This accounts for a safe product to be used by the oral route, with potential benefits for the immune system.

Entities:  

Keywords:  Imuno TF; characterization; peptides; proteomics; safety profile; transfer factor

Year:  2021        PMID: 33947143     DOI: 10.3390/biom11050665

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  24 in total

Review 1.  ER-mediated phagocytosis: a new membrane for new functions.

Authors:  Michel Desjardins
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

2.  The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes.

Authors:  H S LAWRENCE
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

3.  Purification of transfer factors.

Authors:  S J Rozzo; C H Kirkpatrick
Journal:  Mol Immunol       Date:  1992-02       Impact factor: 4.407

Review 4.  Transfer factor: past, present and future.

Authors:  H H Fudenberg; H H Fudenberg
Journal:  Annu Rev Pharmacol Toxicol       Date:  1989       Impact factor: 13.820

5.  Orally administered HSV-specific transfer factor (TF) prevents genital or labial herpes relapses.

Authors:  G Pizza; D Viza; C De Vinci; A Palareti; D Cuzzocrea; V Fornarola; R Baricordi
Journal:  Biotherapy       Date:  1996

Review 6.  A new basis for the immunoregulatory activities of transfer factor--an arcane dialect in the language of cells.

Authors:  H S Lawrence; W Borkowsky
Journal:  Cell Immunol       Date:  1983-11       Impact factor: 4.868

7.  Transfer factor for the prevention of varicella-zoster infection in childhood leukemia.

Authors:  R W Steele; M G Myers; M M Vincent
Journal:  N Engl J Med       Date:  1980-08-14       Impact factor: 91.245

8.  Talin Plays a Critical Role in the Maintenance of the Regulatory T Cell Pool.

Authors:  Jane E Klann; Kelly A Remedios; Stephanie H Kim; Patrick J Metz; Justine Lopez; Lauren A Mack; Ye Zheng; Mark H Ginsberg; Brian G Petrich; John T Chang
Journal:  J Immunol       Date:  2017-05-17       Impact factor: 5.422

9.  Treatment of childhood combined Epstein-Barr virus/cytomegalovirus infection with oral bovine transfer factor.

Authors:  J F Jones; L L Minnich; W S Jeter; R F Pritchett; V A Fulginiti; R J Wedgwood
Journal:  Lancet       Date:  1981-07-18       Impact factor: 79.321

10.  Comparative study of transfer factor and acyclovir in the treatment of herpes zoster.

Authors:  S Estrada-Parra; A Nagaya; E Serrano; O Rodriguez; V Santamaria; R Ondarza; R Chavez; B Correa; A Monges; R Cabezas; C Calva; I Estrada-Garcia
Journal:  Int J Immunopharmacol       Date:  1998-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.